Ondine Biomedical Inc. (OBI.L)
LSE - LSE Delayed Price. Currency in GBp (0.01 GBP)
Add to watchlist
At close: 04:45PM BST
| Previous Close | 5.12 |
| Open | 5.00 |
| Bid | 6.00 x N/A |
| Ask | 7.00 x N/A |
| Day's Range | 5.00 - 7.00 |
| 52 Week Range | 5.00 - 19.35 |
| Volume | |
| Avg. Volume | 324,103 |
| Market Cap | 14.966M |
| Beta (5Y Monthly) | -0.15 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.06 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
Ondine Biomedical’s nasal photodisinfection named as leading photonics biomedical technology for its potential to safely combat AMR
VANCOUVER, British Columbia, November 13, 2023--Ondine Biomedical’s Steriwave nasal photodisinfection technology has been shortlisted in the biomedical category of the 2024 international society for optics and photonics SPIE Prism Awards. Ondine’s nasal photodisinfection technology, which has been significantly reducing hospital acquired infections, uses a combination of a photosensitive agent and red laser light to eliminate bacteria, viruses, and fungi in the nose in minutes without generating
Simply Wall St.Ondine Biomedical Full Year 2022 Earnings: CA$0.10 loss per share (vs CA$0.63 loss in FY 2021)
Ondine Biomedical ( LON:OBI ) Full Year 2022 Results Key Financial Results Net loss: CA$19.4m (loss narrowed by 61...
© 2024 Yahoo. All rights reserved.